Cancer research can put beauty in an otherwise devastating disease

In this image: Lung cancer cells driven by the KRAS oncogene show up in purple in this image from a genetically engineered mouse model. As a key driver in many types of cancer, the KRAS gene makes a promising target for new cancer therapies – KRAS stands for “Kirsten rat sarcoma viral oncogene homologue”

“KRAS mutations are present in approximately 25% of tumors, making them one of the most common gene mutations linked to cancer. They are frequent drivers in lung, colorectal and pancreatic cancers. KRAS drives 32% of lung cancers, 40% of colorectal cancers, and 85% to 90% of pancreatic cancer cases.”

Source: https://www.mdanderson.org/cancerwise/targeting-the-kras-mutation-for-more-effective-cancer-treatment.h00-159458478.html
Thanks to National Cancer Institute @NCI https://visualsonline.cancer.gov/details.cfm?imageid=10549

Source: National Cancer Institute \ Huntsman Cancer Institute at the Univ. of Utah
Creator: Eric Snyder

#Cancer #Cells #Research #UNSW #UNSWChemEng #UNSWMedicine